Arcadia Biosciences, Inc. (RKDA) News
Filter RKDA News Items
RKDA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
RKDA News Highlights
- For RKDA, its 30 day story count is now at 6.
- Over the past 22 days, the trend for RKDA's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about RKDA are BG and CALM.
Latest RKDA News From Around the Web
Below are the latest news stories about ARCADIA BIOSCIENCES INC that investors may wish to consider to help them evaluate RKDA as an investment opportunity.
Zacks Industry Outlook Highlights Bunge, CalMaine Foods and Arcadia BiosciencesBunge, CalMaine Foods and Arcadia Biosciences are part of the Zacks Industry Outlook article. |
3 Stocks to Watch in the Promising Agriculture - Products IndustryThe Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend. |
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights Conference CallDAVIS, Calif., March 22, 2023--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its 2022 fourth-quarter and full-year financial and business results after market close on March 30, 2023. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayWe're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on! |
Arcadia Biosciences (RKDA) Announces $6.0 Million Private Placement Priced at a Premium to Market Under Nasdaq RulesArcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 666,334 shares of its common stock (or common stock equivalents), Series A preferred investment options to purchase up to an aggregate of 666,334 shares of common stock and Series B preferred investment options to purchase up to an aggregate of 666,334 shares of common stock |
SPX, Nasdaq Eye 3-Straight LossesFollowing a retreat in jobless claims, interest rates are at the forefront of investors' minds this afternoon. |
We're Hopeful That Arcadia Biosciences (NASDAQ:RKDA) Will Use Its Cash WiselyWe can readily understand why investors are attracted to unprofitable companies. For example, although... |
Arcadia Biosciences' GoodWheat pasta receives 'Heart Check' certification from American Heart AssociationThe American Heart Association's certification of the health value of Arcadia's GoodWheat pasta could support its new consumer packaged good brand with marketing. |
GoodWheat™ Pasta Receives American Heart Association® Heart-Check CertificationGoodWheat™ pasta is breaking new ground in helping consumers make healthier food choices by receiving the American Heart Association's Heart-Check mark on all five varieties of its single ingredient noodles. Consumers who are looking for heart-healthy wheat pasta can now enjoy great taste along with 8g of fiber and 9g of protein per serving. |
3 Stocks Worth a Look in the Thriving Agriculture - Products IndustryWith the Agriculture - Products industry set to gain from solid demand, stocks like Bunge Limited (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend. |